Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRIVE vs Conventional Sedation for Fiberoptic Intubation in Difficult Airways
NCT04924621Unknown
- Sponsor
- Peking University
- Start
- Jun 2021
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Peking University. Primary endpoints: Blood oxygen pressure at Day 0, Pulse oxygen saturation at Day 0 and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT04924621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04924621.